){kind=logo}
Loeb & Loeb LLP is pleased to announce that FDA Regulatory and Compliance partner Scott Liebman will be a speaker at the 3rd Alzheimer’s focused #C4CT (Coalition for Concussion Treatment) Concussion Awareness Summit on Thursday, July 31, 2014, at the United Nations.
The Summit will explore the potential link between traumatic brain injury and Alzheimer’s disease. A diverse working group of clinicians, medical researchers, policy makers, diplomats, athletes, celebrities, and philanthropic organizations will assemble to raise awareness, advance clinical research, and develop public policy to address this major unmet medical need and public health issue.
Mr. Liebman will speak on a Public Policies panel addressing regulatory issues affecting the development pathways of drugs and biotech.
The Summit will explore the potential link between traumatic brain injury and Alzheimer’s disease. A diverse working group of clinicians, medical researchers, policy makers, diplomats, athletes, celebrities, and philanthropic organizations will assemble to raise awareness, advance clinical research, and develop public policy to address this major unmet medical need and public health issue.
Mr. Liebman will speak on a Public Policies panel addressing regulatory issues affecting the development pathways of drugs and biotech.